Multicenter Study to Evaluate the Effectiveness and Safety of Flow-Diverting Stents for Distal Intracranial Aneurysms

Exclusion Criteria

• •1. Conditions that are not appropriate for stent delivery and deployment judged by investigators (severe stenosis of parent artery, severe tortuosity of parent artery, stent failing to reach the lesion, stent in the target lesion of parent artery, etc.)
• •2. mRS score ≥3
• •3. Heart, lung, liver and renal failure or other severe diseases (intracranial tumor, systemic infection, disseminated intravascular coagulation, myocardial infarction within 12 months before enrollment, history of severe psychosis, severe stenosis or occlusion of cerebral feeding artery, etc.)
• •4. Platelet count \<60×10\^9/L, known platelet dysfunction, or international normalized ratio (INR) \>1.5
• •5. Major surgery within 30 days before enrollment，or planned to undergo surgery within 360 days after enrollment
• •6. Known allergies or contraindications to anesthetics, anticoagulants, and antiplatelet drugs
• •7. Pregnant or breastfeeding women
• •8. Subject has participated in other clinical trials within 1 month before signing informed consent
• •9. Other conditions judged by the investigators as unsuitable for enrollment